200 related articles for article (PubMed ID: 17280604)
21. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL
J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388
[TBL] [Abstract][Full Text] [Related]
22. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor.
White MR; Crouch E; van Eijk M; Hartshorn M; Pemberton L; Tornoe I; Holmskov U; Hartshorn KL
Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L831-40. PubMed ID: 15608147
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary surfactant protein D in first-line innate defence against influenza A virus infections.
Hillaire ML; Haagsman HP; Osterhaus AD; Rimmelzwaan GF; van Eijk M
J Innate Immun; 2013; 5(3):197-208. PubMed ID: 23391661
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies.
Hartshorn KL; Reid KB; White MR; Jensenius JC; Morris SM; Tauber AI; Crouch E
Blood; 1996 Apr; 87(8):3450-61. PubMed ID: 8605364
[TBL] [Abstract][Full Text] [Related]
25. Conglutinin acts as an opsonin for influenza A viruses.
Hartshorn KL; Sastry K; Brown D; White MR; Okarma TB; Lee YM; Tauber AI
J Immunol; 1993 Dec; 151(11):6265-73. PubMed ID: 8245465
[TBL] [Abstract][Full Text] [Related]
26. Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain.
van Eijk M; White MR; Crouch EC; Batenburg JJ; Vaandrager AB; Van Golde LM; Haagsman HP; Hartshorn KL
J Immunol; 2003 Aug; 171(3):1431-40. PubMed ID: 12874235
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody-assisted structure-function analysis of the carbohydrate recognition domain of surfactant protein D.
Hartshorn KL; White MR; Rynkiewicz M; Sorensen G; Holmskov U; Head J; Crouch EC
Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L384-92. PubMed ID: 20601494
[TBL] [Abstract][Full Text] [Related]
28. Surfactant protein A and surfactant protein D variation in pulmonary disease.
Sorensen GL; Husby S; Holmskov U
Immunobiology; 2007; 212(4-5):381-416. PubMed ID: 17544823
[TBL] [Abstract][Full Text] [Related]
29. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
[TBL] [Abstract][Full Text] [Related]
30. A unique sugar-binding site mediates the distinct anti-influenza activity of pig surfactant protein D.
van Eijk M; Rynkiewicz MJ; White MR; Hartshorn KL; Zou X; Schulten K; Luo D; Crouch EC; Cafarella TR; Head JF; Haagsman HP; Seaton BA
J Biol Chem; 2012 Aug; 287(32):26666-77. PubMed ID: 22685299
[TBL] [Abstract][Full Text] [Related]
31. The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus.
Hsieh IN; De Luna X; White MR; Hartshorn KL
Front Immunol; 2018; 9():1368. PubMed ID: 29951070
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera.
White MR; Crouch E; Chang D; Sastry K; Guo N; Engelich G; Takahashi K; Ezekowitz RA; Hartshorn KL
J Immunol; 2000 Aug; 165(4):2108-15. PubMed ID: 10925296
[TBL] [Abstract][Full Text] [Related]
33. Multiple components contribute to ability of saliva to inhibit influenza viruses.
White MR; Helmerhorst EJ; Ligtenberg A; Karpel M; Tecle T; Siqueira WL; Oppenheim FG; Hartshorn KL
Oral Microbiol Immunol; 2009 Feb; 24(1):18-24. PubMed ID: 19121065
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins.
Hartshorn KL; White MR; Shepherd V; Reid K; Jensenius JC; Crouch EC
Am J Physiol; 1997 Dec; 273(6):L1156-66. PubMed ID: 9435570
[TBL] [Abstract][Full Text] [Related]
35. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D.
Leth-Larsen R; Garred P; Jensenius H; Meschi J; Hartshorn K; Madsen J; Tornoe I; Madsen HO; Sørensen G; Crouch E; Holmskov U
J Immunol; 2005 Feb; 174(3):1532-8. PubMed ID: 15661913
[TBL] [Abstract][Full Text] [Related]
36. Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses.
van Eijk M; Bruinsma L; Hartshorn KL; White MR; Rynkiewicz MJ; Seaton BA; Hemrika W; Romijn RA; van Balkom BW; Haagsman HP
J Biol Chem; 2011 Jun; 286(23):20137-51. PubMed ID: 21489996
[TBL] [Abstract][Full Text] [Related]
37. Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses.
Tecle T; White MR; Gantz D; Crouch EC; Hartshorn KL
J Immunol; 2007 Jun; 178(12):8046-52. PubMed ID: 17548642
[TBL] [Abstract][Full Text] [Related]
38. Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense.
Hartshorn KL
Front Biosci (Schol Ed); 2010 Jan; 2(2):527-46. PubMed ID: 20036966
[TBL] [Abstract][Full Text] [Related]
39. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.
Hartshorn KL; Webby R; White MR; Tecle T; Pan C; Boucher S; Moreland RJ; Crouch EC; Scheule RK
Respir Res; 2008 Sep; 9(1):65. PubMed ID: 18811961
[TBL] [Abstract][Full Text] [Related]
40. Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein.
Hartshorn KL; Sastry KN; Chang D; White MR; Crouch EC
Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L90-8. PubMed ID: 10645895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
